Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung

7680685940018 CH-68594 Injektionslösung
Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung
Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung
Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung
1 / 3
google

Article details

Package size
10 x 2 ml
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/01/2025
Summary of Product Characteristics
Français
09/01/2025
Summary of Product Characteristics
Italien
09/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
18.66 MG Substance HBESI

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
68594
Drug name
Sugammadex Ideogen, Injektionslösung
Galenic form
LSINJ
ATC Code
V03AB35
Authorization status
Z
Dispensing category
B
First authorization
03/11/2023
Authorization expiration date
02/11/2028
IT Number
15.01.0.
Domain
Human medicine
Field of application
Aufhebung der durch Recuronium oder Vecuronium induzierten neuromuskulären Blockade

Package details

Description (FR)
SUGAMMADEX Ideogen sol inj 200 mg/2ml 10 x 2 ml
Description (DE)
SUGAMMADEX Ideogen Inj Lös 200 mg/2ml 10 x 2 ml
Market launch
03/11/2023
Narcotic (BTM)
No

Other package sizes (1)

SUGAMMADEX Ideogen sol inj 500 mg/5ml 10 x 5 ml
10 x 5 ml DUR
GTIN: 7680685940025
View